PATENT CLAIM ANALYSIS

Application Number: 15917555
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "275000"]

Abstract:
Provided are compounds having HDAC6 modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by HDAC6.

Claim (Index 6):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein each of R 1  and R 2  is, independently, hydrogen, alkyl, haloalkyl, aryl, cycloalkyl, \u2014CH 2 OR f , \u2014(CH 2 ) n NR a C(O)R b , \u2014C(O)NR a R b , or \u2014(CR h R i ) n -E-NR d SO 2 R d , wherein each R 1  and R 2  is optionally substituted with 1-3 independent substituents R 5 .

Metadata:
- Claim Count in Document: 74.0
- Percentile: 90.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15763972', '15858015', '15815809', '15857950', '12843702']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7804228230262725
- 35 USC 102 Novelty (BERT): 0.5560278196266247
- Combined Prediction Score: 0.7579833226863077
- Mean Citation Score: 381.424428
- Max Citation Score: 410.94333
- Similarity Product: 331.2376144851959

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test